References
- Caselli A, Hanane T, Jane B, et al. Topical methylnicotinate-induced skin vasodilation in diabetic neuropathy. J Diabet Complicat. 2003;17:205–210.
- Cevc G, Blume G. New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, transfersomes. Biochim Biophys Acta. 2001;1514:191–205.
- Che Jun, Yang Yu. Determination of matrine oxgmatrine content in Kangfuling capsules by HPLC. Chin J Trad Chin Med Pharm. 2007;5:1–4.
- Chen R, Gu X, Wu F. Simultaneous determination of matrine and oxymatrine in “matrine suppository” by RP-HPLC. Shangh J Trad Chin Med. 2007;41:66–68.
- Dawson JB, Barker DJ, Ellis DJ, et al. A theoretical and experimental study of light absorption and scattering by in vivo skin. Phys Med Biol. 1980;25:696–709.
- Dayan N, Touitou E. Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes. Biomaterials. 2000;21:1879–1885.
- Fang YP, Tsai YH, Wu PC, et al. Comparison of 5-aminolevulinic acid-encapsulated liposome versus ethosomes for skin delivery for photodynamic therapy. Int J Pharm. 2008;356(1–2):144–152.
- Feng X, Xu D, Xu X. Study on percutaneous permeation of naloxone ethosomes. Chin JMAP. 2008;25:37–39.
- Furneri PM, Fresta M, Puglisi G, et al. Ofloxacin-loaded liposomes: in vitro activity and drug accumulation in bacteria. Antimicrob Agents Chemother. 2000;44:2458–2464.
- Godin B, Touitou E. Mechanism of bacitracin permeation enhancement through the skin and cellular membranes from an ethosomal carrier. J Contr Rel. 2004;94(2–3):365–379.
- Huang Z, Shao L. Effects of matrine on the in vitro growth and the expression of adhesion molecule of human hepatoma cell SMMC-7721. Shand Med J. 2006;46(32):24–25.
- Jain S, Tiwary AK, Sapra B, et al. Formulation and evaluation of ethosomes for transdermal delivery of lamivudine. AAPS PharmSciTech. 2007;8:E111.
- Jia Y, Liu D, Song Q. Effect of traditional Chinese medicine unguent on epidermal growth factor and local wound healing in rabbit ear scar models. J Clin Rehab Tissue Engin Res. 2007;11:9859–9862.
- Jiang H. Research progress on the pharmacological action and preparation of matrine and oxymatrine. Pract Clin J Integrat Trad Chin West Med. 2007;7: 89–90.
- Jumbelic LC, Liebel FT, Southall MD. Establishing a minimal erythema concentration of methyl nicotinate for optimum evaluation of anti-inflammatories. Skin Pharmacol Physio. 2006;19:147–152.
- Lambrecht R, Clarys P, Clijsen R, et al. Determination of the in vivo bioavailability of iontophoretically delivered diclofenac using a methyl nicotinate skin inflammation assay. Skin Res Technol. 2006;12:211–216.
- Li B, Yang B. Studies on the effect of quinidine/quinine and matrine/oxymatrine on HERG channel and structure activity relationships. Chin Pharmacol. 2007;24:29–29.
- Li C. Simultaneous determination of matrine and oxymatrine in Zhidai tablets by HPLC. Chin Trad Pat Med. 2007;29:307–309.
- Li J, Chen X, Feng D. Preparation and quality control of matrine gel. J Trad Chin Med Univ Hun. 2007;27:31–32.
- Li W, Guo D. Study of the therapeutic effect of chronic hepatitis B by sequential therapy using lamivudine combined with matrine. Qingh Med J. 2006;36:15–16.
- Liang Y. Research progress on the pharmacological action of oxymatrine. Chin Pharm. 2005;16:465–466.
- Lodzki M, Godin B, Rakou L, et al. Cannabidiol-transdermal delivery and anti-inflammatory effect in a murine model. J Contr Rel. 2003;93:377–387.
- Rao Y-F, Li F, Liang W. Study on transdermal permeation and skin accumulation of finasteride ethosomes. Chin Pharm J. 2004;139:923–925.
- Remane Y, Leopold CS. Time of erythema onset after application of methyl nicotinate ointments as response parameter: influence of penetration kinetics and enhancing agents. Skin Pharmacol Physiol. 2006;19:303–310.
- Tan X, Zhang Z, Li J. Experiment of transdermal absorption in vitro of matrine in xiaoliuzhitong babu plaster. Chin Trad Pat Med. 2000;22:760–761.
- Tian J, Wang W, Gao H, et al. Determination of matrine, sophoridine, and oxymatrine in compound Kushen injection by HPLC. Chin J Chin Materia Medica. 2007;32:222–224.
- Touitou E, Godin B, Dayan N, et al. Intracellular delivery mediated by an ethosomal carrier. Biomaterials. 2001;22:3053–3059.
- Touitou E, Dayan N, Bergelson L, et al. Ethosomes-novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Contr Rel. 2000;65:403.
- Wang J, Wang G. The pharmacological action and clinical application of matrine and oxymatrine. Chin Hepatol. 2000;5:116–117.
- Wei H, Li Z, Wang Q, et al. Studies on pharmacokinetics and bioavailability of matrine creams. Chin Pharmaceut J. 2001;36:183–185.
- Wu G, Tong H, Shen G, et al. Determination of matrine and oxymatrine in Fudekang foaming agent by HPLC. Chin Pharmac. 2007;10:989–991.
- Yang X, Zhao B, Ju Y. Antifungal activities and synergetic tests of matrine and oxymatrine to some tree pathogens. J Nanj Forest Univ (Nat Sci Ed). 2007;32:79–82.
- Zhang Xiuming, Liu Xiaoping, Li Hui. HPLC determination of matrine in matrine liposome. J Chin Med Mat. 2007;30: 97–99.
- Zhang Y, Du J, Zhang Y, et al. Effects of matrine, oxymatrine, and resveratrol on HERG channel expression. Acta Pharmaceut Sin. 2007;42:139–144.